Caplight Logo









Comprehensive Blood & Cancer Center

Comprehensive Blood & Cancer Center

Private
Bakersfield, CaliforniaHealthcare & Life Scienceshttps://cbccusa.com

Last Round

Private Equity

May 27, 2025

Total Funding Raised

$6M

Company Overview

Comprehensive Blood & Cancer Center (CBCC) is a major cancer treatment and research facility located in Bakersfield, California. Founded in 1984 by Dr. Ravi Patel, CBCC provides a wide range of services including medical oncology, hematology, radiation oncology, diagnostic imaging, genetic testing, and clinical trials. The center is the only one in the Central Valley selected as a research site by the UCLA Jonsson Comprehensive Cancer Center, giving patients access to cutting-edge clinical trials. CBCC also has a partnership with Dignity Health to enhance its level of care. The organization has grown from a small office to a large campus with over 250 employees, focused on a patient-first philosophy that combines advanced technology with compassionate care. CBCC also operates a global research division that conducts clinical trials in various fields.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Imaging, Clinical Trials

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cancer centercomprehensive cancer caremedical oncologyradiation oncologyblood disorder treatmentclinical trialsoncology clinicimmunotherapytargeted therapydiagnostic imagingCyberKnife radiosurgerygenetic testingfreestanding cancer centerpalliative carenaturopathic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Comprehensive Blood & Cancer Center Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Comprehensive Blood & Cancer Center Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 27, 2025
Series AApr 12, 2013

Comprehensive Blood & Cancer Center Investors

Notable investors and investment history

InvestorRounds
Western & Southern Financial GroupPrivate Equity
Edgewater Capital PartnersPrivate Equity

Comprehensive Blood & Cancer Center Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Comprehensive Blood & Cancer Center Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Comprehensive Blood & Cancer Center's valuation, stock price, and market status.

Firmographic Details

HeadquartersBakersfield, California
Employee Range126
Year Founded1984
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.